Does TOCILIZUMAB Cause Injection site erythema? 392 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 392 reports of Injection site erythema have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.4% of all adverse event reports for TOCILIZUMAB.
392
Reports of Injection site erythema with TOCILIZUMAB
0.4%
of all TOCILIZUMAB reports
0
Deaths
71
Hospitalizations
How Dangerous Is Injection site erythema From TOCILIZUMAB?
Of the 392 reports, 71 (18.1%) required hospitalization, and 12 (3.1%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 392 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which TOCILIZUMAB Alternatives Have Lower Injection site erythema Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE